Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 185

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis

Open access
Harknett, E.C., Chang, W.Y.C., Byrnes, S., Johnson, J., Lazor, R., Cohen, M.M., Gray, B., Geiling, S., Telford, H., Tattersfield, A.E., Hubbard, R.B., Johnson, S.R. · 2011 · QJM: An International Journal of Medicine

Abstract

BACKGROUND: Understanding the true prevalence of lymphangioleiomyomatosis (LAM) is important in estimating disease burden and targeting specific interventions. As with all rare diseases, obtaining reliable epidemiological data is difficult and requires innovative approaches. AIM: To determine the prevalence and incidence of LAM using data from patient organizations in seven countries, and to use the extent to which the prevalence of LAM varies regionally and nationally to determine whether prevalence estimates are related to health-care provision. METHODS: Numbers of women with LAM were obtained from patient groups and national databases from seven countries (n = 1001). Prevalence was calculated for regions within countries using female population figures from census data. Incidence estimates were calculated for the USA, UK and Switzerland. Regional variation in prevalence and changes in incidence over time were analysed using Poisson regression and linear regression. RESULTS: Prevalence of LAM in the seven countries ranged from 3.4 to 7.8/million women with significant variation, both between countries and between states in the USA. This variation did not relate to the number of pulmonary specialists in the region nor the percentage of population with health insurance, but suggests a large number of patients remain undiagnosed. The incidence of LAM from 2004 to 2008 ranged from 0.23 to 0.31/million women/per year in the USA, UK and Switzerland. CONCLUSION: Using this method, we have found that the prevalence of LAM is higher than that previously recorded and that many patients with LAM are undiagnosed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/qjmed/hcr116

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 185

Metadata

Authors
Harknett, E. C., Chang, W. Y. C., Byrnes, S., Johnson, J., Lazor, R., Cohen, M. M., Gray, B., Geiling, S., Telford, H., Tattersfield, A. E., Hubbard, R. B., & Johnson, S. R.
Venue
QJM: An International Journal of Medicine
Published
2011-07-15
Volume
104
Issue
11
Pages
971-979
ISSN
  • 0033-5622 (ISSN-L)
  • 1460-2393
  • 1460-2725
OpenAlex
W2110250763
Cited by
185
References
2
FWCI
2.50
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. https://app.cochat.ai/papers/10.1093/qjmed/hcr116
The paper
Harknett, E. C., Chang, W. Y. C., Byrnes, S., Johnson, J., Lazor, R., Cohen, M. M., Gray, B., Geiling, S., Telford, H., Tattersfield, A. E., Hubbard, R. B., & Johnson, S. R. (2011). Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM: An International Journal of Medicine. https://doi.org/10.1093/qjmed/hcr116

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.